| pubmed-article:16612609 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16612609 | lifeskim:mentions | umls-concept:C0035648 | lld:lifeskim |
| pubmed-article:16612609 | lifeskim:mentions | umls-concept:C0038410 | lld:lifeskim |
| pubmed-article:16612609 | lifeskim:mentions | umls-concept:C0282563 | lld:lifeskim |
| pubmed-article:16612609 | lifeskim:mentions | umls-concept:C0205396 | lld:lifeskim |
| pubmed-article:16612609 | lifeskim:mentions | umls-concept:C0007328 | lld:lifeskim |
| pubmed-article:16612609 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:16612609 | pubmed:dateCreated | 2006-6-20 | lld:pubmed |
| pubmed-article:16612609 | pubmed:abstractText | The objective of the case-control study presented here was to examine the risk factors for macrolide-resistant Streptococcus pneumoniae. As part of a 44-center U.S. surveillance study, 1,817 unique isolates of S. pneumoniae were collected from November 2002 through April 2003. Seventy-five randomly selected macrolide-resistant isolates (cases) were each matched with one susceptible control. Macrolide use in the 6 weeks prior to sample collection was reported for seven cases and one control. The final conditional logistic regression model identified two statistically significant variables: a history of alcohol abuse was protective, while macrolide use in the 6 weeks prior to sample collection was a significant risk factor for macrolide-resistant S. pneumoniae. Macrolide resistance was associated with use of any antibiotic during the prior 6 weeks, and was most strongly associated with previous macrolide use. | lld:pubmed |
| pubmed-article:16612609 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16612609 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16612609 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16612609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16612609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16612609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16612609 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16612609 | pubmed:month | May | lld:pubmed |
| pubmed-article:16612609 | pubmed:issn | 0934-9723 | lld:pubmed |
| pubmed-article:16612609 | pubmed:author | pubmed-author:DoernG VGV | lld:pubmed |
| pubmed-article:16612609 | pubmed:author | pubmed-author:DiekemaD JDJ | lld:pubmed |
| pubmed-article:16612609 | pubmed:author | pubmed-author:RichterS SSS | lld:pubmed |
| pubmed-article:16612609 | pubmed:author | pubmed-author:BeekmannS ESE | lld:pubmed |
| pubmed-article:16612609 | pubmed:author | pubmed-author:HeilmannK PKP | lld:pubmed |
| pubmed-article:16612609 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16612609 | pubmed:volume | 25 | lld:pubmed |
| pubmed-article:16612609 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16612609 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16612609 | pubmed:pagination | 335-9 | lld:pubmed |
| pubmed-article:16612609 | pubmed:meshHeading | pubmed-meshheading:16612609... | lld:pubmed |
| pubmed-article:16612609 | pubmed:meshHeading | pubmed-meshheading:16612609... | lld:pubmed |
| pubmed-article:16612609 | pubmed:meshHeading | pubmed-meshheading:16612609... | lld:pubmed |
| pubmed-article:16612609 | pubmed:meshHeading | pubmed-meshheading:16612609... | lld:pubmed |
| pubmed-article:16612609 | pubmed:meshHeading | pubmed-meshheading:16612609... | lld:pubmed |
| pubmed-article:16612609 | pubmed:meshHeading | pubmed-meshheading:16612609... | lld:pubmed |
| pubmed-article:16612609 | pubmed:meshHeading | pubmed-meshheading:16612609... | lld:pubmed |
| pubmed-article:16612609 | pubmed:meshHeading | pubmed-meshheading:16612609... | lld:pubmed |
| pubmed-article:16612609 | pubmed:meshHeading | pubmed-meshheading:16612609... | lld:pubmed |
| pubmed-article:16612609 | pubmed:meshHeading | pubmed-meshheading:16612609... | lld:pubmed |
| pubmed-article:16612609 | pubmed:meshHeading | pubmed-meshheading:16612609... | lld:pubmed |
| pubmed-article:16612609 | pubmed:meshHeading | pubmed-meshheading:16612609... | lld:pubmed |
| pubmed-article:16612609 | pubmed:meshHeading | pubmed-meshheading:16612609... | lld:pubmed |
| pubmed-article:16612609 | pubmed:meshHeading | pubmed-meshheading:16612609... | lld:pubmed |
| pubmed-article:16612609 | pubmed:meshHeading | pubmed-meshheading:16612609... | lld:pubmed |
| pubmed-article:16612609 | pubmed:meshHeading | pubmed-meshheading:16612609... | lld:pubmed |
| pubmed-article:16612609 | pubmed:meshHeading | pubmed-meshheading:16612609... | lld:pubmed |
| pubmed-article:16612609 | pubmed:meshHeading | pubmed-meshheading:16612609... | lld:pubmed |
| pubmed-article:16612609 | pubmed:meshHeading | pubmed-meshheading:16612609... | lld:pubmed |
| pubmed-article:16612609 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16612609 | pubmed:articleTitle | Macrolide use identified as risk factor for macrolide-resistant Streptococcus pneumoniae in a 17-center case-control study. | lld:pubmed |
| pubmed-article:16612609 | pubmed:affiliation | Division of Medical Microbiology, Department of Pathology 265 MRC, University of Iowa, Iowa, IA, 52242, USA. susan-beekmann@uiowa.edu | lld:pubmed |
| pubmed-article:16612609 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16612609 | pubmed:publicationType | Multicenter Study | lld:pubmed |
